-SWN spheroid cell model and that it is a potential treatment of patients who harbor truncating variants located in exon 11.
No takes yet. Share an insight, caveat, or question.
Casals-Sendra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: